The circulating levels of Pro1-Glu2-Ang II were 15% of Ang II in humans, but the Ang II analog increased fivefold in patients with end-stage renal disease that may perhaps reflect a compensatory response in pathological conditions (66). The gene discussed is AGT; the disease is stage 5 chronic kidney disease.